The independent source for health policy research, polling, and news.
581 - 600 of 986 Results
Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the new abortion bans passed in Alabama and Georgia; bipartisan congressional efforts to end “surprise” out-of-network medical bills; and a new public option health insurance plan soon to be available in Washington state.
Kaiser Health News’ Julie Rovner talks about a package of health care bills that Democrats plan to push through the House this week during an interview on “Here and Now.”
The claim by Democratic presidential candidate Eric Swalwell is correct but could use more context and clarification.
A talking point used by House Speaker Nancy Pelosi refers to all three of these distinct concepts in a way that could magnify public misperceptions.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest news about the Trump administration’s effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
Giving consumers more knowledge about the costs of care has long been desired, but administration officials cautioned it could take two years or more for useful data to appear in a phone app.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
In an unusual move, the House Rules Committee, instead of one of the panels that typically oversee health policy, held the first House hearing in a decade about converting the U.S. to a government-financed health care system.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The pesticide chlorpyrifos has been linked to developmental problems in children. Some state and federal lawmakers want the chemical banned, but federal regulators are fighting to keep it on the market.
Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss the latest news about women’s reproductive health policy and the latest skirmish in the debate over “Medicare-for-all”: how hospitals should be paid.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Jennifer Haberkorn of the Los Angeles Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to answer listener questions about the fate of the Affordable Care Act, “Medicare-for-all“ and how to talk about health care costs. Also, for extra credit, the panelists offer their favorite “extra credit” stories of the week.
Julie Rovner of Kaiser Health News talks about the court case challenging the Affordable Care Act and Democratic proposals to expand Medicare on C-SPAN and NPR.
The plan by Sanders has drawn a lot of attention on the campaign trail and Capitol Hill.
Sarah Kliff of Vox.com, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the latest version of a “Medicare-for-all” bill by Sen. Bernie Sanders (I-Vt.), a presidential hopeful, and Democratic and Republican reactions to it. They also discuss the latest on congressional efforts to rein in drug prices and another state effort to expand Medicaid — but not exactly in the way voters wanted. Also, Rovner interviews Ceci Connolly of the Alliance of Community Health Plans.
During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.
The Senate Finance Committee’s third drug-pricing hearing focused on pharmacy benefit managers, and was more of a fact-finding mission on how these companies operate than a debate about policy proposals.
© 2026 KFF